Models and Data Sources Used in Systems Medicine

M. Gietzelt; M. Löpprich; C. Karmen; M. Ganzinger

doi:10.3414/ME15-01-0151

Methods of Information in Medicine, Table of Contents

Methods Inf Med 2016; 55(02): 107-113
DOI: 10.3414/ME15-01-0151

Original Articles

Schattauer GmbH

Models and Data Sources Used in Systems Medicine^[*]

A Systematic Literature Review

M. Gietzelt

¹Institute of Medical Biometry and Informatics, Heidelberg University, Heidelberg, Germany

,

M. Löpprich

¹Institute of Medical Biometry and Informatics, Heidelberg University, Heidelberg, Germany

,

C. Karmen

¹Institute of Medical Biometry and Informatics, Heidelberg University, Heidelberg, Germany

,

M. Ganzinger

¹Institute of Medical Biometry and Informatics, Heidelberg University, Heidelberg, Germany

› Author Affiliations

Abstract

Summary

Background: Systems medicine is a new approach for the development and selection of treatment strategies for patients with complex diseases. It is often referred to as the application of systems biology methods for decision making in patient care. For systems medicine computer applications, many different data sources have to be integrated and included into models. This is a challenging task for Medical Informatics since the approach exceeds traditional systems like Electronic Health Records. To prioritize research activities for systems medicine applications, it is necessary to get an overview over modelling methods and data sources already used in this field.

Objectives: We performed a systematic literature review with the objective to capture current use of 1) modelling methods and 2) data sources in systems medicine related research projects.

Methods: We queried the MEDLINE and ScienceDirect databases for papers associated with the search term systems medicine and related terms. Papers were screened and assessed in full text in a two-step process according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement guidelines.

Results: The queries returned 698 articles of which 34 papers were finally included into the study. A multitude of modelling approaches such as machine learning and network analysis was identified and classified. Since these approaches are also used in other domains, no methods specific for systems medicine could be identified. Omics data are the most widely used data types followed by clinical data. Most studies only include a rather limited number of data sources.

Conclusions: Currently, many different modelling approaches are used in systems medicine. Thus, highly flexible modular solutions are necessary for systems medicine clinical applications. However, the number of data sources included into the models is limited and most projects currently focus on prognosis. To leverage the potential of systems medicine further, it will be necessary to focus on treatment strategies for patients and consider a broader range of data.

Keywords

Systems medicine - systematic literature review - data sources - models - medical informatics

Full Text

References

References
1 Bousquet J, Anto JM, Sterk PJ, Adcock IM, Chung KF, Roca J. et al. Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome medicine 2011; 3 (Suppl. 07) 43.
2 Kaminsky DA, Irvin CG, Sterk PJ. Complex systems in pulmonary medicine: a systems biology approach to lung disease. J Appl Physiol 2011; 110 (Suppl. 06) 1716-1722.
3 Tian Q, Price ND, Hood L. Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine. J Intern Med 2012; 271 (Suppl. 02) 111-121.
4 Tanaka H. Omics-based medicine and systems pathology. A new perspective for personalized and predictive medicine. Methods Inf Med 2010; 49 (Suppl. 02) 173-185.
5 Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine 2009; 6 (Suppl. 07) e1000097.
6 Mayring P. Einführung in die qualitative Sozialforschung: Eine Anleitung zu qualitativem Denken. 5., neu ausgestattete Aufl. Weinheim: Beltz; 2002. (Beltz Studium).
7 Kuckartz U. Qualitative text analysis: A guide to methods, practice & using software. Los Angeles: SAGE; 2014
8 MAXQDA. Qualitative & Mixed Methods Data Analysis Software. Berlin: VERBI GmbH; 2014. Available from: URL: http://www.maxqda.de.
9 ATLAS.ti. Berlin: ATLAS.ti Scientific Software Development GmbH; 2015. Available from: URL: http://atlasti.com.
10 NVivo. Doncaster, Victoria, Australia: QSR International Pty Ltd.; 2015. Available from: URL: http://www.qsrinternational.com.
11 World Health Organization.. The international statistical classification of diseases and related health problems. 10th revision, 2008 edition. Geneva: World Health Organization; 2009
12 Agur Z, Elishmereni M, Kheifetz Y. Personalizing oncology treatments by predicting drug efficacy, side-effects, and improved therapy: mathematics, statistics, and their integration. Wiley Interdiscip Rev Syst Biol Med 2014; 6 (Suppl. 03) 239-253.
13 Alfredo C, Charles A, Alvar A, Giovanni A, Rudi B, Piero B. et al. A Systems Medicine Clinical Platform for Understanding and Managing NonCommunicable Diseases. Curr Pharm Des. 2014
14 Arns M, Drinkenburg WH, Fitzgerald PB, Kenemans, Leon J. Neurophysiological predictors of non-response to rTMS in depression. Brain Stimulation 2012; 5 (Suppl. 04) 569-576.
15 Azuaje F, Devaux Y, Vausort M, Yvorra C, Wagner DR. Transcriptional networks characterize ventricular dysfunction after myocardial infarction: A proof-of-concept investigation. J Biomed Inform 2010; 43 (Suppl. 05) 812-819.
16 Baranzini SE. Systems-based medicine approaches to understand and treat complex diseases. The example of multiple sclerosis. Autoimmunity 2006; 39 (Suppl. 08) 651-662.
17 Bielinski SJ, Olson JE, Pathak J, Weinshilboum RM, Wang L, Lyke KJ. et al. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol. Mayo Clin Proc 2014; 89 (Suppl. 01) 25-33.
18 Bousquet J, Jorgensen C, Dauzat M, Cesario A, Camuzat T, Bourret R. et al. Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies. Curr Pharm Des 2014; 20 (Suppl. 38) 5928-5944.
19 Cardinal-Fernández P, Nin N, Ruíz-Cabello J, Lorente JA. Systems Medicine: A New Approach to Clinical Practice. Arch Bronconeumol. 2014
20 Chen B, Causton HC, Mancenido D, Goddard NL, Perlstein EO, Pe’er D. Harnessing gene expression to identify the genetic basis of drug resistance. Mol Syst Biol 2009; 5: 310.
21 Diamandis M, White Nicole MA, Yousef GM. Personalized medicine: marking a new epoch in cancer patient management. Mol Cancer Res 2010; 8 (Suppl. 09) 1175-1187.
22 Erskine KE, Griffith E, Degroat N, Stolerman M, Silverstein LB, Hidayatallah N. et al. An interdisciplinary approach to personalized medicine: case studies from a cardiogenetics clinic. Per Med 2013; 10 (Suppl. 01) 73-80.
23 Everson RB. Scientific horizons in cancer control: genomes, informatics and personalized medicine. Conn Med 2012; 76 (Suppl. 06) 359-364.
24 Jamshidi N, Miller FJ, Mandel J, Evans T, Kuo MD. Individualized therapy of HHT driven by network analysis of metabolomic profiles. BMC Syst Biol 2011; 5: 200.
25 Jing X, Kay S, Marley T, Hardiker NR, Cimino JJ. Incorporating personalized gene sequence variants, molecular genetics knowledge, and health knowledge into an EHR prototype based on the Continuity of Care Record standard. J Biomed Inform 2012; 45 (Suppl. 01) 82-92.
26 Kouris I, Tsirmpas C, Mougiakakou SG, Iliopoulou D, Koutsouris D. E-Health towards ecumenical framework for personalized medicine via Decision Support System. Conf Proc IEEE Eng Med Biol Soc 2010; 2010; pp 2881-2885.
27 Lebeda FJ, Cer RZ, Stephens RM, Mudunuri U. Temporal characteristics of botulinum neurotoxin therapy. Expert Rev Neurother 2010; 10 (Suppl. 01) 93-103.
28 Li Nicole Y K, Abbott KV, Rosen C, An G, Hebda PA, Vodovotz Y. Translational systems biology and voice pathophysiology. Laryngoscope 2010; 120 (Suppl. 03) 511-515.
29 Menden MP, Iorio F, Garnett M, McDermott U, Benes CH, Ballester PJ. et al. Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties. PLoS One 2013; 8 (Suppl. 04) e61318.
30 Nevins JR, Huang ES, Dressman H, Pittman J, Huang AT, West M. Towards integrated clinico genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Hum Mol Genet 2003; 12 Spec No 2 R153-157.
31 Noble SL, Sherer E, Hannemann RE, Ramkrishna D, Vik T, Rundell AE. Using adaptive model predictive control to customize maintenance therapy chemotherapeutic dosing for childhood acute lymphoblastic leukemia. J Theor Biol 2010; 264 (Suppl. 03) 990-1002.
32 Pattini L, Sassi R, Cerutti S. Dissecting heart failure through the multiscale approach of systems medicine. IEEE Trans Biomed Eng 2014; 61 (Suppl. 05) 1593-1603.
33 Pemovska T, Kontro M, Yadav B, Edgren H, Eldfors S, Szwajda A. et al. Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia. Cancer Discov 2013; 3 (Suppl. 12) 1416-1429.
34 Pendergrass SA, Verma SS, Holzinger ER, Moore CB, Wallace J, Dudek SM. et al. Next-generation analysis of cataracts: determining knowledge driven gene-gene interactions using Biofilter, and gene-environment interactions using the PhenX Toolkit. Pac Symp Biocomput 2013: 147-158.
35 Prague M, Commenges D, Thiebaut R. Dynamical models of biomarkers and clinical progression for personalized medicine: the HIV context. Adv Drug Deliv Rev 2013; 65 (Suppl. 07) 954-965.
36 Seddon JM, Reynolds R, Yu Y, Rosner B. Validation of a prediction algorithm for progression to advanced macular degeneration subtypes. JAMA Ophthalmol 2013; 131 (Suppl. 04) 448-455.
37 Sittka A, Vera J, Lai X, Schmeck BT. Asthma phenotyping, therapy, and prevention: what can we learn from systems biology?. Pediatr Res 2013; 73 4 Pt 2 543-552.
38 Spencer KL, Olson LM, Schnetz-Boutaud N, Gallins P, Agarwal A, Iannaccone A. et al. Using genetic variation and environmental risk factor data to identify individuals at high risk for age- related macular degeneration. PLoS One 2011; 6 (Suppl. 03) e17784.
39 Spronk D, Arns M, Barnett KJ, Cooper NJ, Gordon E. An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: A pilot study. Journal of Affective Disorders 2011; 128 1–2 41-48.
40 Stojadinovic A, Elster E, Potter BK, Davis TA, Tadaki DK, Brown TS. et al. Combat Wound Initiative program. Mil Med 2010; 175 (Suppl. 07) 18-24.
41 Urbanowicz RJ, Andrew AS, Karagas MR, Moore JH. Role of genetic heterogeneity and epistasis in bladder cancer susceptibility and outcome: a learning classifier system approach. J Am Med Inform Assoc 2013; 20 (Suppl. 04) 603-612.
42 Villoslada P, Baranzini S. Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosis. J Neuroimmunol 2012; 248 1–2 58-65.
43 Volzke H, Schmidt CO, Baumeister SE, Ittermann T, Fung G, Krafczyk-Korth J. et al. Personalized cardiovascular medicine: concepts and methodological considerations. Nat Rev Cardiol 2013; 10 (Suppl. 06) 308-316.
44 Wang K, Lee I, Carlson G, Hood L, Galas D. Systems biology and the discovery of diagnostic biomarkers. Dis Markers 2010; 28 (Suppl. 04) 199-207.
45 R: A Language and Environment for Statistical Computing. Vienna, Austria: 2013 Available from: URL: http://www.R-project.org.
46 MATLAB. Natick, MA, USA: The MathWorks, Inc.; 1994 –2015 Available from: URL: http://www.mathworks.com/products/matlab.
47 Chenomx NMR Suite. Edmonton, Alberta, Canada: Chenomx Inc.; 2015 Available from: URL: http://www.chenomx.com/software/software.php.
48 Wang L, Khankhanian P, Baranzini SE, Mousavi P. iCTNet: a Cytoscape plugin to produce and analyze integrative complex traits networks. BMC bioinformatics 2011; 12: 380.
49 Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez Gene: gene-centered information at NCBI. Nucleic acids research 2005; 33 Database issue D54-58.
50 Vandamme D, Fitzmaurice W, Kholodenko B, Kolch W. Systems medicine: helping us understand the complexity of disease. QJM 2013; 106 (Suppl. 10) 891-895.
51 Nibbe RK, Chowdhury SA, Koyutürk M, Ewing R, Chance MR. Protein-protein interaction networks and subnetworks in the biology of disease. Wiley Interdiscip Rev Syst Biol Med 2011; 3 (Suppl. 03) 357-367.
52 Bertalanffy L von. An outline of general system theory. Br J Philos Sci 1950; I (Suppl. 02) 134-165.
53 Murdoch TB, Detsky AS. The inevitable application of big data to health care. JAMA 2013; 309 (Suppl. 13) 1351-1352.
54 Tan SS, Gao G, Koch S. Big Data and Analytics in Healthcare. Methods Inf Med 2015; 54 (Suppl. 06) 546-547.
55 Swan M. Health 2050: The Realization of Personalized Medicine through Crowdsourcing, the Quantified Self, and the Participatory Biocitizen. Journal of personalized medicine 2012; 2 (Suppl. 03) 93-118.

Supplementary Material

Models and Data Sources Used in Systems Medicine[*]

Models and Data Sources Used in Systems Medicine^[*]